亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01061 亿胜生物科技

已收盘 04-14 16:08:05

4.590

+0.270

+6.25%

最高4.610	最低4.340	成交量158.00万
今开4.340	昨收4.320	日振幅6.25%
总市值26.04亿	流通市值26.04亿	总股本5.67亿
成交额708.69万	换手率0.28%	流通股本5.67亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01061","market":"HK","secType":"STK","nameCN":"亿胜生物科技","latestPrice":4.59,"timestamp":1744618085028,"preClose":4.32,"halted":0,"volume":1580000,"delay":0,"floatShares":567294000,"shares":567294000,"eps":0.54137,"marketStatus":"已收盘","change":0.27,"latestTime":"04-14 16:08:05","open":4.34,"high":4.61,"low":4.34,"amount":7086899,"amplitude":0.0625,"askPrice":4.59,"askSize":35000,"bidPrice":4.56,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.531815,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744680600000},"marketStatusCode":5,"adr":0,"listingDate":993571200000,"exchange":"SEHK","adjPreClose":4.32,"dividendRate":0.026144,"openAndCloseTimeList":[[1744594200000,1744603200000],[1744606800000,1744617600000]],"volumeRatio":0.364139,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01061","defaultTab":"news","newsList":[{"id":"2527925070","title":"亿胜生物科技盘中异动 快速拉升5.09%报4.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527925070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527925070?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:20","pubTimestamp":1744600812,"startTime":"0","endTime":"0","summary":"2025年04月14日早盘11时20分，亿胜生物科技股票出现波动，股价大幅上涨5.09%。截至发稿，该股报4.540港元/股，成交量58.3万股，换手率0.10%，振幅4.63%。资金方面，该股资金流入161.276万港元，流出89.545万港元。亿胜生物科技股票所在的药品行业中，整体涨幅为0.55%。亿胜生物科技公司简介：亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414112012aa2c6dc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414112012aa2c6dc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2517361995","title":"亿胜生物科技03月05日主力净流入31万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517361995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517361995?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:16","pubTimestamp":1741162574,"startTime":"0","endTime":"0","summary":"03月05日, 亿胜生物科技股价涨2.14%，报收2.86元，成交金额106万元，换手率0.07%，振幅3.57%，量比1.42。亿胜生物科技今日主力资金净流入31万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.69%，主力资金累计净流入31万元；近20日主力资金累计净流入138万元，其中净流入天数为2日。该股主力净额占比0.02%，港股市场排名313/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170225a2605a34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170225a2605a34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01061"],"gpt_icon":0},{"id":"2514543889","title":"亿胜生物科技(01061)注销7万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2514543889","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514543889?lang=zh_cn&edition=full","pubTime":"2025-02-26 17:09","pubTimestamp":1740560950,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，该公司于2025年2月26日注销7万股已回购股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"gpt_icon":0},{"id":"2510833630","title":"亿胜生物科技(01061)2月10日斥资7.65万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2510833630","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510833630?lang=zh_cn&edition=full","pubTime":"2025-02-10 16:38","pubTimestamp":1739176696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2025年2月10日斥资7.65万港元回购股份3万股，每股回购价格为2.55港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2509794873","title":"亿胜生物科技(01061)2月7日斥资10.28万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509794873","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509794873?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:49","pubTimestamp":1738918195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2025年2月7日，该公司斥资10.28万港元回购4万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"gpt_icon":0},{"id":"2509721563","title":"亿胜生物科技(01061)下跌6.3%，报2.53元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509721563","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509721563?lang=zh_cn&edition=full","pubTime":"2025-02-06 13:38","pubTimestamp":1738820303,"startTime":"0","endTime":"0","summary":"2月6日，亿胜生物科技(01061)盘中下跌6.3%，截至13:38，报2.53元/股，成交117.98万元。亿胜生物科技有限公司主要业务是生产和销售治疗体表创伤和眼部损伤的生物药品，同时也代理分销和推广第三方医药产品。该公司已成功开发出一系列基因工程生物药品，其中三项产品被归类为国家级I类新药，主要品牌包括贝复济、贝复舒和贝复新。截至2024年中报，亿胜生物科技营业总收入7.41亿元、净利润1.44亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/06133847981023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2509742535","title":"亿胜生物科技盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509742535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509742535?lang=zh_cn&edition=full","pubTime":"2025-02-05 13:21","pubTimestamp":1738732917,"startTime":"0","endTime":"0","summary":"2025年02月05日下午盘13时21分，亿胜生物科技股票出现波动，股价大幅下挫5.07%。亿胜生物科技股票所在的药品行业中，整体跌幅为0.04%。其相关个股中，中国医疗集团、三爱健康集团、艾美疫苗涨幅较大，振幅较大的相关个股有中国医疗集团、李氏大药厂、和黄医药，振幅分别为13.41%、7.03%、6.44%。亿胜生物科技公司简介：亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205132157961884bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205132157961884bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2506232179","title":"亿胜生物科技(01061)1月27日注销5.3万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2506232179","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506232179?lang=zh_cn&edition=full","pubTime":"2025-01-27 17:43","pubTimestamp":1737970981,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2025年1月27日，该公司注销5.3万股已回购股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2503582122","title":"亿胜生物科技1月13日耗资5.39万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2503582122","media":"格隆汇","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503582122?lang=zh_cn&edition=full","pubTime":"2025-01-13 17:37","pubTimestamp":1736761025,"startTime":"0","endTime":"0","summary":"格隆汇1月13日丨亿胜生物科技(01061.HK)发布公告，2025年1月13日耗资5.39万港元回购2万股，回购价格每股2.68-2.71港元。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011317425796020a85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011317425796020a85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01061"],"gpt_icon":0},{"id":"2503373382","title":"亿胜生物科技(01061)1月13日斥资5.39万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2503373382","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503373382?lang=zh_cn&edition=full","pubTime":"2025-01-13 17:21","pubTimestamp":1736760083,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2025年1月13日该公司斥资5.39万港元回购2万股，回购价格为每股2.68-2.71港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1236792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2501170057","title":"亿胜生物科技(01061)1月8日斥资9.21万港元回购3.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2501170057","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501170057?lang=zh_cn&edition=full","pubTime":"2025-01-08 16:45","pubTimestamp":1736325909,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2025年1月8日斥资9.21万港元回购股份3.3万股，每股回购价格为2.79-2.8港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1234881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2501278138","title":"亿胜生物科技1月7日收盘下跌2.76%，成交67.68万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501278138","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501278138?lang=zh_cn&edition=full","pubTime":"2025-01-07 17:11","pubTimestamp":1736241118,"startTime":"0","endTime":"0","summary":"1月7日，截至港股收盘，恒生指数下跌1.22%，报19447.58点。亿胜生物科技收报2.82港元/股，下跌2.76%，成交量23.9万股，成交额67.68万港元，振幅3.1%。最近一个月来，亿胜生物科技累计跌幅2.08%，今年来累计跌幅4.08%，跑输恒生指数-3.05%的跌幅。财务数据显示，截至2024年6月30日，亿胜生物科技实现营业总收入7.41亿元，同比减少9.75%；归母净利润1.44亿元，同比减少7.29%；毛利率89.28%，资产负债率32.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010717151395fb56ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010717151395fb56ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2501402070","title":"【亿胜生物科技(01061.HK)：HLX04-O的国际多中心三期临床研究近日完成最后一名患者的最后一次访视】亿胜生物科技(01061.HK)发布公告，用以治疗湿性AMD的anti-VEGF眼用注射生物药品HLX04-O的国际多中心三期临床研究近日完成最后一名患者的最后一次访视。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501402070","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501402070?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:37","pubTimestamp":1736152678,"startTime":"0","endTime":"0","summary":"亿胜生物科技(01061.HK)发布公告，用以治疗湿性AMD的anti-VEGF眼用注射生物药品HLX04-O的国际多中心三期临床研究近日完成最后一名患者的最后一次访视。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/06163747154675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1923623000.USD","LU0823421416.USD","LU0642271901.SGD","GFS","IE0004445239.USD","BK4573","IE00B5949003.HKD","LU0390134368.USD","LU0082616367.USD","LU1880398554.USD","LU2360106780.USD","LU1951200564.SGD","BK4588","LU0823434740.USD","BK4141","BK4529","LU2098885051.SGD","LU1803068979.SGD","BK4512","LU2458330243.SGD","LU0127658192.USD","LU1316542783.SGD","01061","LU1242518931.SGD","BK4534","LU1988902786.USD","LU0081259029.USD","LU1951198990.SGD","IE00BMPRXN33.USD","LU0979878070.USD","IE00BMPRXR70.SGD","BK4566","BK4554","LU0198837287.USD","LU0889565833.HKD","LU1303367103.USD","LU2458330169.SGD","IE0009356076.USD","LU2054465674.USD","BK4532","LU0109392836.USD","LU2250418816.HKD","LU2264538146.SGD","LU0823434583.USD","LU1064131342.USD","LU0719512351.SGD","BK1161","BK4575","LU0823421333.USD"],"gpt_icon":0},{"id":"2501031402","title":"亿胜生物科技(01061)：HLX04-O的国际多中心三期临床研究近日完成最后一名患者的最后一次访视","url":"https://stock-news.laohu8.com/highlight/detail?id=2501031402","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501031402?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:33","pubTimestamp":1736152434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技 发布公告，用以治疗湿性AMD的anti-VEGF眼用注射生物药品HLX04-O的国际多中心三期临床研究近日完成最后一名患者的最后一次访视。此三期临床研究是一项在湿性AMD患者中开展的随机、双盲、阳性对照及全球的研究，旨在比较HLX04-O与雷珠单抗的有效性和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1233762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2501407953","title":"亿胜生物科技：与复宏汉霖就渗出性(湿性)老年性黄斑部病变的治疗共同开发许可产品国际多中心三期临床研究完成最后一名患者的最后一次访视","url":"https://stock-news.laohu8.com/highlight/detail?id=2501407953","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501407953?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:33","pubTimestamp":1736152430,"startTime":"0","endTime":"0","summary":"格隆汇1月6日丨亿胜生物科技公布，有关受许人与复宏汉霖订立共同开发许可协议，以根据共同开发许可协议之条款共同开发许可产品及向受许人授出有关许可产品之独家权利。用以治疗湿性AMD之anti-VEGF眼用注射生物药品HLX04-O的国际多中心三期临床研究近日完成最后一名患者的最后一次访视。此三期临床研究是一项在湿性AMD患者中开展的随机、双盲、阳性对照及全球的研究，旨在比较HLX04-O与雷珠单抗的有效性和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106163350aba03105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106163350aba03105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01061","02696"],"gpt_icon":0},{"id":"2501071154","title":"亿胜生物科技(01061.HK)治疗眼部药物完成患者访视","url":"https://stock-news.laohu8.com/highlight/detail?id=2501071154","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501071154?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:31","pubTimestamp":1736152260,"startTime":"0","endTime":"0","summary":"亿胜生物科技(01061.HK) 公布，用以治疗湿性老年性黄斑部病变(AMD)之重组抗血管内皮生长因子人源化单克隆抗体(anti-VEGF)眼用注射生物药品“HLX04-O”的国际多中心三期临床研究，于近日完成最后一名患者的最后一次访视。据介绍，“HLX04-O”是在复宏汉霖自主研发的汉贝泰®的基础上，根据眼科用药的需求对汉贝泰®的处方、规格和生产工艺进行优化，在活性成分不变的基础上，开发的新的眼科制剂产品，拟用于湿性AMD的治疗。(js/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230517145835678_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230517145835678_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1408167/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2495590031","title":"亿胜生物科技(01061)12月30日注销16.5万股已购回股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2495590031","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495590031?lang=zh_cn&edition=full","pubTime":"2024-12-30 16:40","pubTimestamp":1735548042,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2024年12月30日该公司注销16.5万股已购回股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2494934448","title":"亿胜生物科技(01061.HK)玻璃酸钠滴眼液获批于中国商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2494934448","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494934448?lang=zh_cn&edition=full","pubTime":"2024-12-27 01:48","pubTimestamp":1735235280,"startTime":"0","endTime":"0","summary":"亿胜生物科技(01061.HK) 公布，附属广东汉丰已取得国家药品监督管理局批准于中国(不包括香港、澳门及台湾)注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)。获批产品适用于治疗及缓解各种内源性眼部疾病、外源性眼部疾病以及因手术、药物、外伤和/或配戴隐形眼镜所造成的损伤。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230517145836273_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230517145836273_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1406287/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01061","BK1161"],"gpt_icon":0},{"id":"2494007200","title":"亿胜生物科技：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2494007200","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494007200?lang=zh_cn&edition=full","pubTime":"2024-12-26 10:03","pubTimestamp":1735178580,"startTime":"0","endTime":"0","summary":"　　亿胜生物科技发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液。集团其他不含防腐剂单剂量滴眼液产品为妥布霉素滴眼液、左氧氟沙星滴眼液、玻璃酸钠滴眼液、贝复舒滴眼液、盐酸莫西沙星滴眼液及地夸磷索钠滴眼液。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-26/doc-ineatxus9959772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","01061"],"gpt_icon":0},{"id":"2493709189","title":"亿胜生物科技(01061)：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2493709189","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493709189?lang=zh_cn&edition=full","pubTime":"2024-12-24 18:23","pubTimestamp":1735035785,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技 发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液。集团其他不含防腐剂单剂量滴眼液产品为妥布霉素滴眼液、左氧氟沙星滴眼液、玻璃酸钠滴眼液、贝复舒滴眼液、盐酸莫西沙星滴眼液及地夸磷索钠滴眼液。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1229065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技(01061)：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.essexbio.com","stockEarnings":[{"period":"1week","weight":-0.1074},{"period":"1month","weight":0.5652},{"period":"3month","weight":0.554},{"period":"6month","weight":0.4897},{"period":"1year","weight":1.0159},{"period":"ytd","weight":0.4694}],"compareEarnings":[{"period":"1week","weight":-0.0847},{"period":"1month","weight":-0.1138},{"period":"3month","weight":0.0971},{"period":"6month","weight":-0.0159},{"period":"1year","weight":0.2234},{"period":"ytd","weight":0.0426}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。该公司以重组DNA技术为基础开发生物药品。该公司的主要品牌有贝复济、贝复舒和贝复新。该公司通过两个业务分部进行运营。外科分部从事制造与销售贝复济液体制剂、贝复济冻干粉及贝复新凝胶。眼科分部从事制造与销售贝复舒滴眼液、贝复舒眼用凝胶及贝复舒单剂量滴眼液。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.03025},{"month":2,"riseRate":0.642857,"avgChangeRate":0.055827},{"month":3,"riseRate":0.571429,"avgChangeRate":0.056067},{"month":4,"riseRate":0.5,"avgChangeRate":0.038478},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.024881},{"month":6,"riseRate":0.461538,"avgChangeRate":0.047392},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.042257},{"month":8,"riseRate":0.357143,"avgChangeRate":-0.002449},{"month":9,"riseRate":0.5,"avgChangeRate":0.03544},{"month":10,"riseRate":0.357143,"avgChangeRate":0.027853},{"month":11,"riseRate":0.5,"avgChangeRate":0.011053},{"month":12,"riseRate":0.357143,"avgChangeRate":-0.012777}],"exchange":"SEHK","name":"亿胜生物科技","nameEN":"ESSEX BIO-TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.0","shortVersion":"4.33.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿胜生物科技,01061,亿胜生物科技股票,亿胜生物科技股票老虎,亿胜生物科技股票老虎国际,亿胜生物科技行情,亿胜生物科技股票行情,亿胜生物科技股价,亿胜生物科技股市,亿胜生物科技股票价格,亿胜生物科技股票交易,亿胜生物科技股票购买,亿胜生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}